Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27532455)

Published in PLoS Genet on August 17, 2016

Authors

Wei Sun1, Katerina Kechris2, Sean Jacobson3, M Bradley Drummond4, Gregory A Hawkins5, Jenny Yang1, Ting-Huei Chen1, Pedro Miguel Quibrera6, Wayne Anderson7, R Graham Barr8, Patricia V Basta9, Eugene R Bleecker5, Terri Beaty10, Richard Casaburi11, Peter Castaldi12, Michael H Cho12, Alejandro Comellas13, James D Crapo14, Gerard Criner15, Dawn Demeo16, Stephanie A Christenson17, David J Couper6, Jeffrey L Curtis18, Claire M Doerschuk7, Christine M Freeman19, Natalia A Gouskova6, MeiLan K Han20, Nicola A Hanania21, Nadia N Hansel22, Craig P Hersh12, Eric A Hoffman23, Robert J Kaner24, Richard E Kanner25, Eric C Kleerup26, Sharon Lutz2, Fernando J Martinez27, Deborah A Meyers5, Stephen P Peters28, Elizabeth A Regan29, Stephen I Rennard30, Mary Beth Scholand25, Edwin K Silverman12, Prescott G Woodruff31, Wanda K O'Neal32, Russell P Bowler33, SPIROMICS Research Group, COPDGene Investigators

Author Affiliations

1: Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
2: Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States of America.
3: National Jewish Health, Denver, Colorado, United States of America.
4: Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
5: Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
6: Collaborative Studies Coordinating Center, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
7: Marsico Lung Institute/Cystic Fibrosis Research Center, Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina United States of America.
8: Department of Medicine, Columbia University Medical Center, New York, New York; Department of Epidemiology, Mailman School of Public Health at Columbia University, New York, New York, United States of America.
9: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
10: Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University,Baltimore, Maryland, United States of America.
11: Division of Respiratory and Critical Care Physiology and Medicine, Harbor- University of California at Los Angeles Medical Center, Torrance, California, United States of America.
12: Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.
13: Division of Pulmonary and Critical Care Medicine, University of Iowa, Iowa City, Iowa, United States of America.
14: Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colorado, United States of America.
15: Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.
16: Division of Pulmonary and Critical Care Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
17: Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of San Francisco Medical Center, University of California San Francisco, San Francisco, California, United States of America.
18: Graduate Program in Immunology, University of Michigan Medical School, Ann Arbor, Michigan; Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Medical Service, VA Ann Arbor Healthcare System, Ann Arbor, Michigan;
19: Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan; VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States of America.
20: Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan, United States of America.
21: Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, Texas, United States of America.
22: Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
23: Department of Radiology, Division of Physiologic Imaging, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States of America.
24: Department of Genetic Medicine, Weill Cornell Medical College, New York, New York, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical College, New York, New York, United States of America.
25: Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, Utah, United States of America.
26: Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
27: Department of Medicine, Weill Cornell Medical College, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States of America.
28: Department of Medicine, Division of Pulmonary, Critical Care, Allergy and Immunologic Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America.
29: Department of Medicine, National Jewish Health, Denver, Colorado United States of America.
30: Division of Pulmonary and Critical Care Medicine, University of Nebraska, Omaha, Nebraska, United States of America.
31: Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine and Cardiovascular Research Institute, University of California San Francisco School of Medicine, San Francisco, California, United States of America.
32: Marsico Lung Institute/Cystic Fibrosis Research Center, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina United States of America.
33: Department of Medicine, Division of Pulmonary Medicine, National Jewish Health, Denver, Colorado, United States of America.

Associated clinical trials:

Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) (COPDGene) | NCT00608764

Study of COPD Subgroups and Biomarkers (SPIROMICS) | NCT01969344

Articles cited by this

PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Causal diagrams for epidemiologic research. Epidemiology (1999) 19.48

The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res (2013) 14.23

LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics (2010) 13.54

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Variations in DNA elucidate molecular networks that cause disease. Nature (2008) 12.04

An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet (2005) 11.40

Common regulatory variation impacts gene expression in a cell type-dependent manner. Science (2009) 11.28

HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res (2011) 11.03

Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science (2015) 9.92

Genetic studies of body mass index yield new insights for obesity biology. Nature (2015) 8.27

Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67

Human metabolic individuality in biomedical and pharmaceutical research. Nature (2011) 6.56

Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet (2014) 5.78

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet (2011) 5.26

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet (2008) 4.75

Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet (2008) 4.69

Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet (2010) 4.36

An atlas of genetic influences on human blood metabolites. Nat Genet (2014) 3.21

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18

Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77

Effects of exposure measurement error when an exposure variable is constrained by a lower limit. Am J Epidemiol (2003) 2.65

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood (2009) 2.64

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One (2012) 2.52

Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med (2014) 2.28

Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits. Nat Genet (2011) 2.27

Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet (2010) 2.05

Heritability and genomics of gene expression in peripheral blood. Nat Genet (2014) 2.00

Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax (2013) 1.99

Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS One (2012) 1.96

Harnessing naturally randomized transcription to infer regulatory relationships among genes. Genome Biol (2007) 1.94

A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet (2011) 1.92

Genomic variation. Impact of regulatory variation from RNA to protein. Science (2014) 1.91

Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet (2010) 1.89

Disentangling molecular relationships with a causal inference test. BMC Genet (2009) 1.84

Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax (2013) 1.82

Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol (2009) 1.80

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 1.79

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J (2009) 1.56

Genome-wide association study indicates two novel resistance loci for severe malaria. Nature (2012) 1.52

Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51

Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol (1977) 1.50

Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One (2011) 1.43

A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet (2012) 1.37

Rich annotation of DNA sequencing variants by leveraging the Ensembl Variant Effect Predictor with plugins. Brief Bioinform (2014) 1.32

A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor. Pharmacogenomics J (2010) 1.31

Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol (2013) 1.30

Imputation-based meta-analysis of severe malaria in three African populations. PLoS Genet (2013) 1.25

A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost (2012) 1.23

Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet (2010) 1.23

A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet (2012) 1.23

The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol (2011) 1.17

Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association. Proc Natl Acad Sci U S A (2012) 1.16

Critical reasoning on causal inference in genome-wide linkage and association studies. Trends Genet (2010) 1.15

Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15

Lessons from ECLIPSE: a review of COPD biomarkers. Thorax (2013) 1.13

Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2013) 1.12

A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet (2013) 1.12

Genome-wide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci. PLoS Genet (2011) 1.10

Detection of eQTL modules mediated by activity levels of transcription factors. Bioinformatics (2007) 1.08

Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease. Am J Hum Genet (2012) 1.05

Genetic predictors of fibrin D-dimer levels in healthy adults. Circulation (2011) 1.05

Identification of cis-regulatory variation influencing protein abundance levels in human plasma. Hum Mol Genet (2012) 1.02

From genome to function by studying eQTLs. Biochim Biophys Acta (2014) 1.00

Identification of genetic variants influencing the human plasma proteome. Proc Natl Acad Sci U S A (2013) 1.00

Global and regional trends in COPD mortality, 1990-2010. Eur Respir J (2015) 0.99

Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. PLoS Genet (2013) 0.97

Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels. Am J Hum Genet (2014) 0.96

A genome wide association study identifies common variants associated with lipid levels in the Chinese population. PLoS One (2013) 0.95

Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis. Hum Mol Genet (2013) 0.95

A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk. Gut (2013) 0.94

Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study. J Transl Med (2014) 0.93

Genome-wide association study of metabolic traits reveals novel gene-metabolite-disease links. PLoS Genet (2014) 0.91

A genome-wide association study of circulating galectin-3. PLoS One (2012) 0.89

The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes. Respir Res (2014) 0.88

Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients. Respir Res (2015) 0.87

Serum concentrations of C3 and C4 of the complement system in patients with chronic obstructive pulmonary disease. J Lab Clin Med (1980) 0.87

Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry. N Engl J Med (2015) 0.84

Alterations in immunoglobulin & complement levels in chronic obstructive pulmonary disease. Indian J Med Res (1990) 0.83

Proteomic studies related to genetic determinants of variability in protein concentrations. J Proteome Res (2013) 0.82

Genome-wide association study on serum alkaline phosphatase levels in a Chinese population. BMC Genomics (2013) 0.81

Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Biomarker of Emphysema and the RAGE Axis in the Lung. Am J Respir Crit Care Med (2015) 0.81

Employment arrangements and mental health in a cohort of working Australians: are transitions from permanent to temporary employment associated with changes in mental health? Am J Epidemiol (2014) 0.80

The Effect of Statins on Blood Gene Expression in COPD. PLoS One (2015) 0.79

Genome-Wide Association Study Identification of Novel Loci Associated with Airway Responsiveness in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol (2015) 0.79

Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China. PLoS One (2014) 0.78

Evidence for an association between ABO blood group and goitre. Hum Genet (1976) 0.76

ABO blood groups, intestinal alkaline phosphatase and haptoglobin types in patients with serum hepatitis. Hum Hered (1988) 0.76

Articles by these authors

Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54

Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med (2016) 5.23

Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med (2011) 4.75

Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30

Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax (2013) 2.88

The clinical features of the overlap between COPD and asthma. Respir Res (2011) 2.29

Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15

The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest (2011) 2.14

Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med (2011) 2.06

Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax (2013) 1.99

A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98

Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med (2012) 1.80

Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med (2011) 1.76

Racial differences in quality of life in patients with COPD. Chest (2011) 1.64

Association Between Interstitial Lung Abnormalities and All-Cause Mortality. JAMA (2016) 1.61

Genome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patterns. Am J Respir Crit Care Med (2014) 1.57

Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. Ann Am Thorac Soc (2015) 1.54

β-Blockers are associated with a reduction in COPD exacerbations. Thorax (2015) 1.48

Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational study. Lancet Respir Med (2014) 1.41

Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. Invest Radiol (2012) 1.41

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am J Respir Crit Care Med (2012) 1.27

The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med (2013) 1.23

Genome-wide association study of smoking behaviours in patients with COPD. Thorax (2011) 1.18

Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 1.07

Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res (2014) 1.06

Association between airway caliber changes with lung inflation and emphysema assessed by volumetric CT scan in subjects with COPD. Chest (2011) 1.03

Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort. Chest (2011) 1.03

Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res (2013) 1.00

Family history is a risk factor for COPD. Chest (2011) 0.96

Racial differences in CT phenotypes in COPD. COPD (2013) 0.95

Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 0.92

Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes Care (2013) 0.89

Association between occupational exposure and lung function, respiratory symptoms, and high-resolution computed tomography imaging in COPDGene. Am J Respir Crit Care Med (2014) 0.89

Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study. BMC Pulm Med (2016) 0.87

Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 0.87

Analysis of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Defined on the Basis of Bronchodilator Response and Degree of Emphysema. Ann Am Thorac Soc (2016) 0.87

Characterizing functional lung heterogeneity in COPD using reference equations for CT scan-measured lobar volumes. Chest (2013) 0.86

SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs. Am J Respir Crit Care Med (2016) 0.86

Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. BMC Pulm Med (2016) 0.86

Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. Ann Am Thorac Soc (2015) 0.85

Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res (2014) 0.84

Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study. Respir Res (2015) 0.84

"B" for Bad, Beneficial, or Both? Lung Lymphoid Neogenesis in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2015) 0.83

Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study. Genet Epidemiol (2014) 0.82

Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 0.81

Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD (2014) 0.81

Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc (2016) 0.80

Bacterial Topography of the Healthy Human Lower Respiratory Tract. MBio (2017) 0.79

Obesity is Associated with Increased Morbidity in Moderate to Severe COPD. Chest (2016) 0.79

Clinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with Asthma. PLoS One (2015) 0.79

Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function. J Immunol (2015) 0.79

Effect of Emphysema Severity on the Apnea-Hypopnea Index in Smokers with Obstructive Sleep Apnea. Ann Am Thorac Soc (2016) 0.79

CT-derived Biomechanical Metrics Improve Agreement Between Spirometry and Emphysema. Acad Radiol (2016) 0.78

Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene. Respir Med (2014) 0.78

Airway wall thickness is increased in COPD patients with bronchodilator responsiveness. Respir Res (2014) 0.78

Lung Mass in Smokers. Acad Radiol (2016) 0.77

Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 0.77

Current Smoking Status Is Associated With Lower Quantitative CT Measures of Emphysema and Gas Trapping. J Thorac Imaging (2016) 0.77

Childhood-onset asthma in smokers. association between CT measures of airway size, lung function, and chronic airflow obstruction. Ann Am Thorac Soc (2014) 0.77

A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. BMC Genet (2015) 0.77

Biomechanical CT metrics are associated with patient outcomes in COPD. Thorax (2017) 0.77

Sex-specific features of emphysema among current and former smokers with COPD. Eur Respir J (2015) 0.76

Multiplanar MDCT measurement of esophageal hiatus surface area: association with hiatal hernia and GERD. Surg Endosc (2015) 0.76

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat Genet (2017) 0.76

MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. J Immunol (2015) 0.76

Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation. Am J Physiol Lung Cell Mol Physiol (2014) 0.76

A controlled statistical study to assess measurement variability as a function of test object position and configuration for automated surveillance in a multicenter longitudinal COPD study (SPIROMICS). Med Phys (2016) 0.76

A Hairline Crack in the Levee: Focal Secretory IgA Deficiency as a First Step toward Emphysema. Am J Respir Crit Care Med (2017) 0.75

At the Checkpoint: Lung CD8(+) T Cells, Respiratory Viruses, and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 0.75

Acute Exacerbations and Lung Function Loss in Smokers With and Without COPD. Am J Respir Crit Care Med (2016) 0.75

GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease. Respir Res (2017) 0.75

Scavenger Receptor MARCO Orchestrates Early Defenses and Contributes to Fungal Containment during Cryptococcal Infection. J Immunol (2017) 0.75

Post-imaging pulmonary nodule mathematical prediction models: are they clinically relevant? Eur Radiol (2019) 0.75

Ventricular Geometry From Non-contrast Non-ECG-gated CT Scans: An Imaging Marker of Cardiopulmonary Disease in Smokers. Acad Radiol (2017) 0.75

Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers. Chest (2017) 0.75

CT Measure of Lung At-risk and Lung Function Decline in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2017) 0.75

Signs of Gas Trapping in Normal Lung Density Regions in Smokers. Am J Respir Crit Care Med (2017) 0.75

Genetic Association and Risk Scores in a COPD Meta-Analysis of 16,707 Subjects. Am J Respir Cell Mol Biol (2017) 0.75

Variability in objective and subjective measures affects baseline values in studies of patients with COPD. PLoS One (2017) 0.75

Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression. Chest (2017) 0.75

Measurement of Short-Chain Fatty Acids in Respiratory Samples: Keep Your Assay above the Water Line. Am J Respir Crit Care Med (2020) 0.75

Handgrip Strength in Chronic Obstructive Pulmonary Disease. Associations with Acute Exacerbations and Body Composition. Ann Am Thorac Soc (2017) 0.75